Alison Leaf

Alison Leaf is currently the In Silico Translational Medicine Product Line Owner and Sr Director at Sanofi, where they lead efforts in program management, strategic partnerships, and operations within the Tech Bio sector. They have 7.5 years of experience focused on bioinformatics cloud computing platforms, advancing drug discovery and NIH initiatives. Previously, Alison held leadership roles at Seven Bridges, where they managed significant government accounts and oversaw the development of an interoperable data ecosystem, and contributed to innovative platform launches. Alison began their academic journey at Cornell University, earning a Bachelor of Science in Biochemistry, and continued at UCSF, where they completed a Ph.D. in Cellular and Molecular Biology.